Feed 6855.HK
68
Ascentage Pharma Group International
6855.HK · HKSE
$35.90 -3.29% (-$1.22)
1M -4.53%
Market Cap ¥11.9B
P/E Ratio -
Div. Yield -
ROE -
Valuation
0 /100
Expensive P/B 8.95x
P/S 21.20x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 48.01%
Rev. growth 38.67%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 211.14%
Gross margin 76.41%
FCF margin 214.87%
Quality
3 /100
Poor Asset turnover 0.14x
ROIC 33.50%
ROA 30.53%
Debt
37 /100
Moderate Int. coverage -22.42x
Debt/Equity 1.49x
Current ratio 1.79x
Stability
26 /100
Unstable EPS volatility 110.19%
Beta 0.66x
Profitable years 0
Vprašajte StockBota o 6855.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Prihajajoči dogodki
19 AVG.
Earnings
Upcoming earnings report